Stay up to date with the latest breaking news, analysis and commentary on Mirae Asset Sharekhan. Find live updates, exchanges, stock news, earning news and more.
Zydus Lifesciences Ltd have an exclusive agreement to make the Shield Multi-Cancer Detection (MCD) test available in India, for which Zydus has signed a Memorandum of Understanding (MoU) with Apollo Hospitals to offer the test in the territory.
At 12.23 pm, Zydus Lifesciences Ltd was trading at Rs. 1,127, up by 2.49%, with a volume of 0.86 lakh shares on the BSE.
Jewali wind project by Tata Power Renewables
3 Jul 2026, 3:08PMIndian Hume Pipe surges 8% on bagging Rs. 739 crore Rajasthan PHED water supply project
3 Jul 2026, 3:00PML&T wins order for Power Transmission & Distribution Business in Saudi Arabia
29-10-2025 10:13:15The ePlane Company signs MOU with Ramco Systems
27-10-2025 12:42:39Refex Industries gets an order worth Rs. 300 Cr from a mining entity in Jharkhand
24-10-2025 13:57:18Diwali Stocks Picks 2025
